BeOne Medicines
ONC
#735
Rank
NZ$58.40 B
Marketcap
NZ$562.96
Share price
-0.27%
Change (1 day)
14.64%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2026 (TTM): NZ$8.25

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is NZ$8.31. In 2025 the company made an earnings per share (EPS) of NZ$4.72 an increase over its 2024 EPS that were of NZ-$10.78.

EPS history for BeOne Medicines from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$8.2574.91%
2025NZ$4.72-143.75%
2024NZ-$10.78
2022NZ-$33.6828.21%
2021NZ-$26.27-19.96%
2020NZ-$32.8320.81%
2019NZ-$27.1731.52%
2018NZ-$20.66417.57%
2017NZ-$3.99-37.16%
2016NZ-$6.35158.95%
2015NZ-$2.45

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
NZ-$0.47-105.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
NZ-$1.64-119.75%๐Ÿ‡บ๐Ÿ‡ธ USA